Description
Release form
Rectal suppositories.
Packing
10 pcs.
Pharmacological action of
Bufexamak (a derivative of aryl acetic acid) has an anti-inflammatory effect. Bismuth subgallate has an astringent effect and promotes wound healing. Titanium dioxide has an astringent and drying effect, promotes wound healing. Lidocaine hydrochloride hydrate is a local anesthetic.
Contraindications
Hypersensitivity to the drug, specific inflammatory processes (syphilis, tuberculosis), childhood, pregnancy, lactation.
Special instructions
In the absence of effect, as well as the appearance of discomfort and other side effects, discontinue use of the drug and consult a doctor. Long-term use of the drug is not recommended. If long-term treatment is necessary, medications that do not contain local anesthetics should be used. With the simultaneous use of Proctosan ® and a condom, a decrease in the strength of condoms may be noted, which reduces their reliability.
Composition
1 suppository contains: bufexamak – 250 mg, bismuth subgallate – 100 mg, titanium dioxide – 100 mg, lidocaine hydrochloride hydrate – 10 mg Excipient: solid fat – 1540 mg.
Dosage and administration
Used rectally, 1 suppository 1-2 times a day, if possible after bowel movement. Continued use of the drug after the abatement of acute events for 8 to 10 days is recommended.
Side effects
Hypersensitivity reactions to the components of the drug are possible (burning, itching, redness of the skin of the perianal zone, edema, the formation of vesicles, flakes, etc.).
Storage conditions
At a temperature not exceeding 25 ° C.
Keep out of the reach of children.
Expiration
5 years. Do not use the drug after the expiration date, indicated on the package.
Active ingredient
Bufesamak, Bismuth subgal titanium dioxide, Lidocaine
Terms and conditions
without prescription
Appointment
Vzrosl m
Indications
Hemorroy, kzema
Shtada Artsnaymittely AG, Germany
